Outlook Therapeutics EPS Diluted from Accounting Change (Quarterly) Analysis

Outlook Therapeutics, Inc. (OTLK)

0.506 -0.01 (-2.69%) USD | NASDAQ | Jan 21, 16:00

0.506 0.00 (0.00%) After-Hours: 05:42

View EPS Diluted from Accounting Change (Quarterly) for OTLK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Accounting Change (Quarterly) Benchmarks

Start Trial

Ironwood Pharmaceuticals, Inc.	--
Amicus Therapeutics, Inc.	--
Neogen Corp.	--
CorMedix, Inc.	--
NovaBay Pharmaceuticals, Inc.	--